Release Date: 16/10/15 18:31 Summary: Renounceable Rights Issue Prospectus Price Sensitive: Yes Download Document 208.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%